Q2 2025 Holdings
Filed 2025-08-14 | 28 holdings | $71.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $9.4M | 1,014,940 | 13.1% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $8.7M | 179,569 | 12.2% |
| Whitehawk Therapeutics Inc(WHWK) | COM | 00032Q104 | $6.4M | 3,410,402 | 8.9% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $5.3M | 63,436 | 7.4% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $4.5M | 283,682 | 6.3% |
| Ascendis PHA(ASND) | SPONSORED ADR | 04351P101 | $3.9M | 22,576 | 5.4% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $3.7M | 37,070 | 5.2% |
| Argen SE(ARGX) | SPONSORED ADR | 04016X101 | $3.7M | 6,702 | 5.2% |
| Praxis Precision Medicines I(PRAX) | COM | 74006W207 | $3.1M | 74,087 | 4.3% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $2.8M | 26,283 | 3.9% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $2.7M | 493,735 | 3.8% |
| Oculis Holding AG(OCS) | ORDINARY SHARES | H5870P102 | $2.1M | 106,718 | 2.9% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $2.0M | 55,693 | 2.9% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $2.0M | 187,257 | 2.8% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $1.7M | 463,864 | 2.4% |
| Surrozen, Inc.(SRZN) | COM NEW | 86889P208 | $1.5M | 170,000 | 2.1% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $1.3M | 48,474 | 1.8% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $1.1M | 485,669 | 1.6% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $1.1M | 19,772 | 1.5% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $1.0M | 83,655 | 1.5% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $945.4K | 75,876 | 1.3% |
| Ultragenyx Pharmaceutical Inc(RARE) | COM | 90400D108 | $865.9K | 23,814 | 1.2% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $624.2K | 150,414 | 0.9% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $410.4K | 59,650 | 0.6% |
| Unicycive Therapeutics Inc(UNCY) | COM | 90466Y202 | $300.0K | 62,899 | 0.4% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $227.4K | 20,000 | 0.3% |
| Artiva Biotherapeutics Inc(ARTV) | COM | 04317A107 | $68.6K | 45,456 | 0.1% |
| Nuvation BIO Inc -Cw27(NUVB/WS) | *W EXP 07/07/2027 | 67080N119 | $24.5K | 90,832 | 0.0% |